[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Press Release: BioMed Central welcomes the new National Institutes of Health Public
- To: "'liblicense-l@lists.yale.edu'" <liblicense-l@lists.yale.edu>
- Subject: Press Release: BioMed Central welcomes the new National Institutes of Health Public
- From: Grace Baynes <Grace@biomedcentral.com>
- Date: Sat, 5 Feb 2005 19:33:26 EST
- Reply-to: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
An announcement from BioMed Central of possible interest to the readers of this list. Apologies for cross-posting. PRESS RELEASE BioMed Central welcomes the new National Institutes of Health Public Access policy London, 4 February 2005 BioMed Central welcomes the announcement of the US National Institutes of Health (NIH) new public access policy. The NIH calls on all of its grantees to deposit articles resulting from their NIH-funded research in the National Library of Medicine's PubMed Central and make them freely available within 12 months. BioMed Central anticipates that many other funding bodies worldwide will now follow the example set by NIH. All NIH grantees now have a new factor to take into account when choosing where they wish to publish their research. To fulfil the NIH request, authors publishing with most of the traditional subscription publishers will be expected to go through a process of resubmitting their papers to the PubMed Central repository. In addition, they will often need to update their manuscript version with the changes introduced in the publication process, as many publishers specify that only the author's version of the manuscript can be submitted to archives. Those who choose to publish in any of BioMed Central's Open Access journals, which cover all areas of biology and medicine, are assured that the published version of their paper will be placed in PubMed Central for them, immediately and without any need for additional work from them. Researchers are thus saved the time and effort of going through the deposition process themselves. This significant benefit is in addition to the rapid and high quality peer review, fast publication and high visibility of BioMed Central's Open Access journals. BioMed Central urges all researchers in the life and medical sciences to fulfil the NIH request and to submit their future manuscripts to one of the 130 Open Access journals published by BioMed Central. The NIH announcement can be found in full at: [http://www.nih.gov/news/pr/feb2005/od-03.htm] ### Press Office Contacts: Grace Baynes for BioMed Central Telephone: +44 (0)20 7631 9988 E-mail: press@biomedcentral.com BioMed Central (http://www.biomedcentral.com) is an independent online publishing house committed to providing immediate access without charge to the peer-reviewed biological and medical research it publishes. This commitment is based on the view that open access to research is essential to the rapid and efficient communication of science. In addition to open-access original research, BioMed Central also publishes reviews and other subscription-based content. This email has been scanned by Postini. For more information please visit http://www.postini.com ###
- Prev by Date: Re: UK select committee response to government on OA
- Next by Date: Re: RE : More on Google
- Previous by thread: Librarians, Publishing Behavior, & Open Access
- Next by thread: NIH plan in daily Chronicle of Higher Education
- Index(es):